Day 1 Notes at the 2020 J.P. Morgan Healthcare Conference

Sheppard Mullin Richter & Hampton LLP
Contact

Sheppard Mullin Richter & Hampton LLP

If I printed a tee shirt for the 2020 J.P. Morgan Healthcare Conference, what would it say? In past years, it would have been “Big Data,” Analytics, Artificial Intelligence, ACA, Risk, Medicare Advantage or Quality. This year, I’d have to say it was: diversification, organic growth and scale. Almost every presentation we attended used those terms, to the point where I wanted to jump up and yell “Bingo! I got it already.” But the message that came through loud and clear this year is that the healthcare industry has figured out what it needs to do and where it needs to go – and that it is creating positive impact for patients while generating good profits by doing so.

The healthcare industry clearly is not at scale yet. As John Starcher, Jr., the Chief Executive Officer of Catholic health system Bon Secours Mercy Health, said, “none of us has scale as we all are under 3% in the US market, that’s not scale.” On the provider side, we continue to see consolidation occur, as we see ongoing health system, physician organization and post-acute mergers and acquisitions. And with continuing revenue growth and strong balance sheets being reported by many of the health systems, there is dry powder for more consolidation in 2020.

And yet, company after company took pains to show substantial organic growth in addition to growth from acquisitions. We saw it with health plans like Centene and with multiple hospital systems. It looked like it was a Lake Wobegone economic statistic, where everyone was growing in their market share, revenue and/or patients, all at the same time. There was a lot of confidence presented, even in markets where the future is uncertain such as the ACA Marketplace (and, no, we did not hear one word today about the ACA Texas court challenge working its way back from the Circuit Court to the district court in Texas).

On the health plan side, the effects of scale are showing. Centene Chief Executive Michael Neidorff noted that Centene will be serving 1 in 15 of Americans after the WellCare acquisition closes, given its diversified product portfolio of Medicaid, Marketplace and Medicare Advantage. Neidorff recounted the effect of their investment in systems and IT at scale – he said that Centene in many states was paying the average doctor in six days or less with greater than 98% accuracy. And analytics can be provided to doctors on an almost real-time basis, with only three days of lag. Neidorff said that having that deep, fresh data has been very helpful in showing the states with which Centene is contracting the true burden of illness and costs of the contracted population, resulting in better contracted rates. “We are becoming in many ways,” Neidorff said, “a technology company that does healthcare.”

Which leads us to Oscar. Bruce Broussard, Chief Executive Officer of Humana today said that Oscar and Devoted Health are changing the experience with customers, making the experience more about health than the insurance product. Oscar’s Chief Executive Officer, Mario Schlosser, showed to a standing room only crowd how Oscar has come of age in 2020, operating in 29 markets with individual, small group and Medicare Advantage products. He shared some fascinating insights into how higher engagement that they have achieved leads not only to greater retention, but also: (1) higher premiums; (2) reduction of network costs, through direction of physician visits to lower cost, quality providers and channeling of prescription drugs to lower cost choices through the establishment of a $3 co-pay for ‘preferred” drugs (much like WalMart does with its employees); and (3) reduces total healthcare costs. Oscar also showed that it has approximately 40% utilization of telemedicine visits by patients with chronic major complex conditions (with almost 30% telemedicine utilization for their general population). Schlosser then took the JPM audience through how easy it is using the Oscar system to drive health behaviors beneficially through their engagement tools. For example, an automated reminder is sent out when it is time for a colorectal screening – but a homekit is offered out as an easy way to undertake the screening. Schlosser reported a 20% uptake on that email campaign, resulting in more screening and at lower overall cost. But wait, there’s more! For patients screened with a positive result, the doctor is prompted to call the patient and discuss the results. For patients where a follow up colonoscopy is then indicated, the plan may then waive the patient co-pay as a way of incentivizing the screening behavior to avoid disease progression and higher, long-term costs to the system overall. For us systems geeks, though, one of the most interesting parts is the way that the engagement tool has been integrated into utilization management and claims processing. When the waiver of co-pay and cost estimate is provided to the patient electronically, it is accompanied by an auto-adjudication in the claims system, resulting in a coordinated and lower cost system operation. As Broussard of Humana said later on Day 1, the focus now is on how to slow disease progression and improve quality and cost. Schlosser continued the technology company metaphor by reminding the audience that large technology companies do about 1,000 A/B tests per day with their products. Imagine changing your insurance benefits or your claims system like that! But the flexibility of the campaigns’ technology, logic and engagement showed a pathway forward.

The other interesting announcement by Oscar and Cigna today was their strategic alliance in the small group employer market under the “Cigna + Oscar” brand in multiple markets in 2020, using Oscar’s engagement and enrollment tools to provide consumer-centric health care coverage with Cigna’s high-performing provider networks. The plans will offer integrated medical, behavioral and pharmacy services, serving the more than 500,000 new companies launching each month that are in need of health coverage for their workers. Oscar and Cigna will share risk equally under a reinsurance agreement. As a shameless self-promotional plug, we also wanted you to know that Sheppard Mullin partners Christine Clements, Eric Klein, Todd Padnos and Adam Shipley represented Cigna in creating this alliance.

Flipping back to the idea of A/B testing (which Google does constantly, for example), it was interesting today to listen to discussions of supplemental benefits under Medicare Advantage which are being enhanced in the market but still have somewhat limited uptake by consumers. Perhaps that is in part either because of a top-down approach or less effective, longer cycle time testing? Bruce Broussard of Humana said that Humana is testing supplemental benefits and seeing what the customer wants. For example, benefits that address a social determinant of health may be offered and then the plan waits to see how that works – how is the customer responding to it, is it raising the costs of other benefits, in essence cannibalizing the insurance product. But, I would note that this is incredibly top-down and slow cycle time – due to the locked in plan benefits and the regulatory environment – likely resulting in less than optimal supplemental benefit profiles that is trying to chase members’ evolving needs and opinions. Imagine now if we could see more bottoms-up design of plan benefits and faster iteration to solve in more real time healthcare problems and frictions.

While traditional Medicare Advantage may not allow such, the CMMI Value Based Insurance Design (VBID) model for 2020 allowed Value-Based Insurance Design by condition, socioeconomic status, or both. Taking advantage of this program may allow for more customized and customizable supplemental benefit designs and more effective testing and iteration of consumer-driven benefit choices. We as an industry should continue to push and expand this faster cycle-time approach, such as perhaps allowed under a well-designed VBID model, to keep pace with technology and the evolution of medical knowledge.

The other interesting trend of the day was diversification. As a matter of fact, it was mentioned so much today that I was ready to start printing tee shirts. On the health plan side, we expect to continue to see diversification of their offerings to include services and tools. Centene’s Neidorff cited to Babylon, Quartet, Wellframe and RxAdvance as diversifying partnerships and said to expect to see a lot more of this type of investment activity coming out of Centene in this area. Humana also will continue to focus on diversification that meets its primary objectives, including slowing disease progress while reducing cost – which means potentially more investments by Humana in provider entities and service capabilities. We also continued to see diversification efforts by health systems, who cited their revenue cycle management offerings, their health plans, their physician entities, their research commercialization, their generic pharmaceutical manufacturing and their pharmacy benefit management services, among others. Interestingly, this included both faith-based and non-faith based systems, as the entire sector is moving toward a broader scope of offerings to both control costs, touch more of the patient premium and anticipate the trend toward value and risk.

Other interesting moments of the day:

  • Concerto HealthAI which is focusing on the application of real word data through AI in the precision oncology space. With a goal of reducing cancer deaths by 25% in the next 10 years, this system works to predict metastatic status and survival rates with precision oncology treatment to better structure, organize and implement clinical trials. They are partnering with Texas Oncology (one of the largest community oncology practices in the country) to apply AI tools to advanced precision medicine.
  • Teladoc’s acquisition of Intouch Health, which provides virtualization tools in the inpatient setting. This extend Teladoc’s continuum from home to office to urgent care to acute setting. Provides more opportunity for revenue growth and addressable market. Teladoc was reporting a 60% CAGR in visits and revenue. Does this also allow for additional solutions for the perennial problem of effective care transitions?
  • Home run of the year – Bon Secours Mercy Health sale of a majority stake of their Ensemble revenue cycle management business, bought by them in 2016 for $60 million, and sold for $1.2 billion in 2019. Pretty good revenue cycle growth!
  • The growth of Navitus, a pharmacy benefit management company owned by SSM Health. Navitus is based on a fully transparent pass-through model, which is an interesting alternative market model to the more traditional rebate based, less transparent model adopted by other PBMs.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sheppard Mullin Richter & Hampton LLP | Attorney Advertising

Written by:

Sheppard Mullin Richter & Hampton LLP
Contact
more
less

Sheppard Mullin Richter & Hampton LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit legal.hubspot.com/privacy-policy.
  • New Relic - For more information on New Relic cookies, please visit www.newrelic.com/privacy.
  • Google Analytics - For more information on Google Analytics cookies, visit www.google.com/policies. To opt-out of being tracked by Google Analytics across all websites visit http://tools.google.com/dlpage/gaoptout. This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.